COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Price & Overview
NASDAQ:CLGN • IL0004960188
Current stock price
The current stock price of CLGN is 0.3817 USD. Today CLGN is up by 2.47%. In the past month the price decreased by -30.5%. In the past year, price decreased by -82.68%.
CLGN Key Statistics
- Market Cap
- 5.504M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.94
- Dividend Yield
- N/A
CLGN Stock Performance
CLGN Stock Chart
CLGN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CLGN. When comparing the yearly performance of all stocks, CLGN is a bad performer in the overall market: 99.01% of all stocks are doing better.
CLGN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CLGN. While CLGN seems to be doing ok healthwise, there are quite some concerns on its profitability.
CLGN Earnings
On March 26, 2026 CLGN reported an EPS of -0.26 and a revenue of 60.00K. The company missed EPS expectations (-34.16% surprise) and missed revenue expectations (-96.14% surprise).
CLGN Forecast & Estimates
8 analysts have analysed CLGN and the average price target is 11.22 USD. This implies a price increase of 2839.48% is expected in the next year compared to the current price of 0.3817.
For the next year, analysts expect an EPS growth of 54.97% and a revenue growth -7.59% for CLGN
CLGN Financial Highlights
Over the last trailing twelve months CLGN reported a non-GAAP Earnings per Share(EPS) of -0.94. The EPS increased by 35.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -106.53% | ||
| ROE | -188.93% | ||
| Debt/Equity | 0 |
CLGN Ownership
CLGN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 12.89 | 360.632B | ||
| AMGN | AMGEN INC | 15.19 | 182.426B | ||
| GILD | GILEAD SCIENCES INC | 14.82 | 159.919B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.03 | 107.655B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.74 | 72.562B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45.44 | 40.188B | ||
| INSM | INSMED INC | N/A | 29.146B | ||
| BIIB | BIOGEN INC | 11.55 | 28.527B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 27.853B | ||
| NTRA | NATERA INC | N/A | 27.602B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.58 | 25.03B | ||
| INCY | INCYTE CORP | 10.72 | 19.722B | ||
| MRNA | MODERNA INC | N/A | 18.132B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CLGN
Company Profile
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Company Info
IPO: 1993-09-01
COLLPLANT BIOTECHNOLOGIES LT
4 Oppenheimer Street, P.O. Box 4132
Rehovot 7670104 IL
CEO: Yehiel Tal
Employees: 39
Phone: 972732325600
COLLPLANT BIOTECHNOLOGIES LT / CLGN FAQ
What does CLGN do?
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
What is the current price of CLGN stock?
The current stock price of CLGN is 0.3817 USD. The price increased by 2.47% in the last trading session.
Does CLGN stock pay dividends?
CLGN does not pay a dividend.
What is the ChartMill rating of COLLPLANT BIOTECHNOLOGIES LT stock?
CLGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in COLLPLANT BIOTECHNOLOGIES LT be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CLGN.
What is the expected growth for CLGN stock?
The Revenue of COLLPLANT BIOTECHNOLOGIES LT (CLGN) is expected to decline by -7.59% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for COLLPLANT BIOTECHNOLOGIES LT?
COLLPLANT BIOTECHNOLOGIES LT (CLGN) has a market capitalization of 5.50M USD. This makes CLGN a Nano Cap stock.